Grifols, S.A. (GRFS) Financials
GRFS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 22.9 billion | 13.8 billion |
| March 31, 2026 | 23.0 billion | 14.0 billion |
| Dec. 31, 2025 | 23.2 billion | 14.2 billion |
| Sept. 30, 2025 | 23.4 billion | 14.5 billion |
GRFS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 123.3 million | ? |
| March 31, 2026 | 67.6 million | ? |
| Dec. 31, 2025 | 348.3 million | ? |
| Sept. 30, 2025 | 299.7 million | ? |
GRFS Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | 326.4 million |
| March 31, 2026 | 85.0 million |
| Dec. 31, 2025 | 365.4 million |
| Sept. 30, 2025 | 149.0 million |
GRFS Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 603.7 million | 8.2 billion | 1.2 billion |
| March 31, 2026 | 805.3 million | 10.4 billion | - |
| Dec. 31, 2025 | 968.1 million | 8.7 billion | 1.1 billion |
| Sept. 30, 2025 | 968.7 million | 10.7 billion | - |
GRFS Shares Outstanding
GRFS Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 135.8 million | 98.1 million | 329.8 million | - |
| March 31, 2026 | 60.6 million | 104.8 million | 327.3 million | - |
| Dec. 31, 2025 | 157.5 million | 159.0 million | 320.2 million | - |
| Sept. 30, 2025 | 82.2 million | 113.9 million | 321.3 million | - |
GRFS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 2.1 billion | 1.3 billion |
| March 31, 2026 | 2.0 billion | 1.3 billion |
| Dec. 31, 2025 | 2.3 billion | 1.5 billion |
| Sept. 30, 2025 | 2.2 billion | 1.3 billion |
GRFS
Price: $7.80
52 week price:
Dividend Yield: 3.60%
Payout Ratio Range:
Earnings Per Share: 0.76 USD
P/E Ratio: 10.36
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: Spain
Volume: 924384
Ebitda: 362.6 millionMarket Capitalization: 6.6 billion
Years Paying Dividends: 2